| Time |
Topic
|
Room
|
Company
|
| 17.30-18.30 |
Tackling the deadly duo of diabetes: Heart failure and Kidney Disease
Carol Pollock (Australia) Chairperson: Surasak Kantachuvessiri
|
Room 1 | Boehringer Ingelheim |
| Time |
Topic
|
Room
|
Company
|
| 12.00-13.30 |
Challenging Paradigms and Changing the Course of CKD Opening Assoc. Prof. Surasak Kantachuvessiri Cardio renal connection and burden of CKD in Asia Pacific Gp. Capt. Pongsathon Gojaseni (Thailand) Early awareness of CKD Prof. Sydney Tang (Hong Kong) New paradigm in CKD management Prof. David Wheeler (UK) Live panel discussion All speakers Chairperson: Assoc. Prof. Surasak Kantachuvessiri (Thailand) |
Room 1 | AstraZeneca |
| 12.00-13.30 |
History of ESAs, the Development of Biosimilars and the Future of Anti-anemic Therapy
Frank Dellanna (Germany)
Challenges and Opportunities of Anemia Management in Emerging Countries
Paweena Susantitaphong (Thailand)Chairperson: Kearkiat Praditpornsilpa (Thailand) |
Room 2 | Bio Leader |
| 12.00-13.30 |
HDx: New era of hemodialysis with MCO: Overview HDx & why improve removal Middle- large is important
Suchai Sritippayawan (Thailand)
Latest Clinical Evidences on HDx and best practices
Colin Hutchison
Clinical Case sharing: HDx in Covid patients
Wanjak Pongsittisak (Thailand)Chairperson: Suchai Sritippayawan (Thailand) |
Room 3 | Baxter |
| Time |
Topic
|
Room
|
Company
|
| 07.30-08.30 |
Managing Resistant Hypertension in 2021: From Guidelines to Practice
Vuddhidej Ophascharoensuk (Thailand)Chairperson: Anutra Chittinandana (Thailand) |
Room 1 | Viatris |
| Time |
Topic
|
Room
|
Company
|
| 12.00-13.30 |
Novel Approach to Anemia in CKD Opening Prof. KriengsakVareesangthip (Thailand) Evolution of HIF science in CKD Anemia Prof. Carol Pollock (Australia) CKD Anemia Management: Insights from China Prof. Hongli Lin (China) Insights from APSN Recommendations on CKD Anemia Assoc. Prof. BanchaSatirapoj (Thailand) Live panel discussion All speakers Chairperson: Prof. KriengsakVareesangthip (Thailand) |
Room 1 | AstraZeneca |
| 12.00-13.30 |
Optimal Therapeutic Strategies in CKD-MBD and CKD Anemia Whom to Treat and When?
Paweena Susantitaphong (Thailand)
Practice Pattern of CKD-MBD and Anemia in Asian Countries
Yusuke Tsukamoto (Japan)Chairperson: Dusit Lumlertgul (Thailand) |
Room 2 | Kyowa Kirin |
| 12.00-13.30 |
Educational Symposium Nipro Sales Biometerials Membrane in Dialysis Treatment (New era of Membrane) Bisphenol A (BPA) Free Membrane Biomaterials
Dusit Lumlertgu (Thailand)
The necessity of ultrapure quality of dialysis fluid and a practical way to achieve
Kolasorn Pakchotanon(Thailand)Chairperson: Surasak Kantachuvesiri(Thailand) |
Room 3 | Nipro Sales |
| 12.00-13.30 |
Importance of The Management of Hyponatremia Best Practices for Management of Hyponatremia and SIADH
Joseph G. Verbalis (US)
Latest Clinical Evidences on HDx and best practices
Colin Hutchison
Tolvaptan in Real-Life Practice (Case Based Sharing)
Kajohnsak Noppakun (Thailand)Chairperson: Kajohnsak Noppakun (Thailand) |
Room 4 | Thai Otsuka |